Keystone Clinical Studies - Ownership and Business Overview

Life ScienceCompany

Keystone Clinical Studies Ownership

Who owns Keystone Clinical Studies?

Keystone Clinical Studies is owned by Flourish Research. It was acquired on October 7, 2022.

Keystone Clinical Studies Business Overview

Where is Keystone Clinical Studies headquartered?

Keystone Clinical Studies is headquartered in Plymouth Meeting, Pennsylvania.

What sector is Keystone Clinical Studies in?

Keystone Clinical Studies is a life science company.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 293 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 256 by strategics.

Keystone Clinical Studies

Keystone Clinical Studies

920 Germantown Pike Suite 102,
Plymouth Meeting, Pennsylvania 19462
United States,
(610) 277-8073
www.keystoneclinicals.com

Keystone Clinical Studies is an independent clinical research study site that conducts Phase 2, 3, and 4 clinical trials for Alzheimer's Disease, Parkinson's Disease, and Depression. Keystone Clinical Studies is based in Plymouth Meeting, Pennsylvania.


 Subscribe to unlock this and 207,325
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.